CIA
CCXI

CSat Investment Advisory’s ChemoCentryx, Inc. CCXI Stock Holding History

CSat Investment Advisory’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-162
Closed -$9K – 1027
2020
Q3 		$9K Buy
162
+22
+16% +$1.18K ﹤0.01% 1060
2020
Q2 		$8K Buy
+140
New +$7.62K ﹤0.01% 1078

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CSat Investment Advisory's CCXI Position: Q4 2020 in Review

CSat Investment Advisory sold out of ChemoCentryx, Inc. (CCXI) in Q4 2020, closing a stake of 162 shares — an estimated $9K sold.

CSat Investment Advisory first reported a position in CCXI in Q2 2020 and held it in 2 quarters. The position peaked at $9K in Q3 2020. 196 funds tracked by Wall St. Rank hold CCXI as of Q4 2020.

  • CSat Investment Advisory reported no remaining ChemoCentryx, Inc. position as of Q4 2020 after selling out during the quarter.
  • CSat Investment Advisory sold 162 ChemoCentryx, Inc. shares in Q4 2020, an estimated $9K.
  • CSat Investment Advisory first reported a position in ChemoCentryx, Inc. in Q2 2020 and held it in 2 quarters.
  • CSat Investment Advisory's ChemoCentryx, Inc. position peaked at $9K in Q3 2020.
  • 196 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2020.

Based on CSat Investment Advisory's 13F filing for Q4 2020, filed 12 Feb 2021.